A pilot study for the Varicella Zoster Vaccine (VERVE) Trial
To evaluate the safety of the Zoster Vaccine in patients using abatacept
Protection against shingles in individuals with rheumatoid arthritis.
50 years or older,
Have rheumatoid arthritis AND currently receiving abatacept.
50 - 95
Healthy Volunteers Needed
Duration of Participation
Up to 1 year
Sarah Siegel 503 494 1384
Bristol Myers Squibb
You will receive $25 for completing the screening visit, and $75 for six-week follow up visit. If you withdraw before the end of the study, you will be paid for the visits you have completed. If you complete the entire study, you will receive $100.